LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | CP724714 | 10 | uM | LJP5 | 1 | A07 | 72 | hr | 868 | 2441 | 3286 | 0.7428 | 0.7131 |
MDA-MB-231 | CP724714 | 10 | uM | LJP5 | 2 | A07 | 72 | hr | 868 | 2070 | 3505 | 0.5905 | 0.5396 |
MDA-MB-231 | CP724714 | 10 | uM | LJP5 | 3 | A07 | 72 | hr | 868 | 2476 | 3440 | 0.7197 | 0.6948 |
MDA-MB-231 | Alvocidib | 0.04 | uM | LJP6 | 1 | A18 | 72 | hr | 868 | 1231 | 3429 | 0.3589 | 0.1927 |
MDA-MB-231 | Alvocidib | 0.04 | uM | LJP6 | 2 | A18 | 72 | hr | 868 | 1272 | 3652 | 0.3483 | 0.2024 |
MDA-MB-231 | Alvocidib | 0.04 | uM | LJP6 | 3 | A18 | 72 | hr | 868 | 1209 | 3587 | 0.3370 | 0.1756 |
MDA-MB-231 | Alvocidib | 0.12 | uM | LJP6 | 1 | A17 | 72 | hr | 868 | 622 | 3429 | 0.1814 | -0.1548 |
MDA-MB-231 | Alvocidib | 0.12 | uM | LJP6 | 2 | A17 | 72 | hr | 868 | 610 | 3652 | 0.1670 | -0.1565 |
MDA-MB-231 | Alvocidib | 0.12 | uM | LJP6 | 3 | A17 | 72 | hr | 868 | 675 | 3587 | 0.1882 | -0.1157 |
MDA-MB-231 | Alvocidib | 0.37 | uM | LJP6 | 1 | A16 | 72 | hr | 868 | 620 | 3429 | 0.1808 | -0.1562 |
MDA-MB-231 | Alvocidib | 0.37 | uM | LJP6 | 2 | A16 | 72 | hr | 868 | 597 | 3652 | 0.1635 | -0.1653 |
MDA-MB-231 | Alvocidib | 0.37 | uM | LJP6 | 3 | A16 | 72 | hr | 868 | 616 | 3587 | 0.1717 | -0.1543 |
MDA-MB-231 | Alvocidib | 1.11 | uM | LJP6 | 1 | A15 | 72 | hr | 868 | 700 | 3429 | 0.2041 | -0.1029 |
MDA-MB-231 | Alvocidib | 1.11 | uM | LJP6 | 2 | A15 | 72 | hr | 868 | 661 | 3652 | 0.1810 | -0.1232 |
MDA-MB-231 | Alvocidib | 1.11 | uM | LJP6 | 3 | A15 | 72 | hr | 868 | 616 | 3587 | 0.1717 | -0.1543 |
MDA-MB-231 | Alvocidib | 3.33 | uM | LJP6 | 1 | A14 | 72 | hr | 868 | 700 | 3429 | 0.2041 | -0.1029 |
MDA-MB-231 | Alvocidib | 3.33 | uM | LJP6 | 2 | A14 | 72 | hr | 868 | 579 | 3652 | 0.1585 | -0.1775 |
MDA-MB-231 | Alvocidib | 3.33 | uM | LJP6 | 3 | A14 | 72 | hr | 868 | 557 | 3587 | 0.1553 | -0.1949 |
MDA-MB-231 | Alvocidib | 10 | uM | LJP6 | 1 | A13 | 72 | hr | 868 | 743 | 3429 | 0.2166 | -0.0755 |
MDA-MB-231 | Alvocidib | 10 | uM | LJP6 | 2 | A13 | 72 | hr | 868 | 611 | 3652 | 0.1673 | -0.1559 |
MDA-MB-231 | Alvocidib | 10 | uM | LJP6 | 3 | A13 | 72 | hr | 868 | 648 | 3587 | 0.1806 | -0.1331 |
MDA-MB-231 | GW843682X | 0.04 | uM | LJP6 | 1 | B18 | 72 | hr | 868 | 3210 | 3429 | 0.9359 | 0.9343 |
MDA-MB-231 | GW843682X | 0.04 | uM | LJP6 | 2 | B18 | 72 | hr | 868 | 2833 | 3652 | 0.7757 | 0.7694 |
MDA-MB-231 | GW843682X | 0.04 | uM | LJP6 | 3 | B18 | 72 | hr | 868 | 2760 | 3587 | 0.7694 | 0.7596 |
MDA-MB-231 | GW843682X | 0.12 | uM | LJP6 | 1 | B17 | 72 | hr | 868 | 2701 | 3429 | 0.7875 | 0.7729 |